| Citation: |
XIE Yuliang, ZHOU Kejian, DENG Mengyu, XIE Xiaoyun, LIANG Tingting, LI Haoying, LIU Jingli. Protective effect of Col003 on the blood-brain barrier after cerebral ischemia-reperfusion injury in rats[J]. Journal of Guangxi Medical University, 2025, 42(2): 202-209. DOI: 10.16190/j.cnki.45-1211/r.2025.02.006
|
To investigate the protective effect of Col003, an inhibitor of heat shock protein 47 (HSP47) on the blood-brain barrier (BBB) after cerebral ischemia-reperfusion injury in rats and its possible mechanism.
The rats were randomly divided into sham group, model group, butylphthalide group, and Col003 group. The middle cerebral artery occlusion (MCAO) model in rats was constructed using the suture occlusion method to simulate cerebral ischemia-reperfusion injury. After removing the suture, the rats in the butylphthalide group were intraperitoneally injected with butylphthalide (5 mg/kg). The rats in the Col003 group were injected with Col003 (50 μmol/L) through the tail vein, and the frequency and duration of administration of both drugs were once a day for 3 consecutive days. In the sham group, only the common carotid artery was isolated. Western blotting was used to detect the expression level of HSP47 in the brain tissues of rats after cerebral ischemia-reperfusion injury. The degree of brain dysfunction and BBB damage was assessed using TTC staining, neurological motor function scores, and Evans blue permeability assays. The effects of Col003 on endothelialmesenchymal transformation (EndMT) induced by cerebral ischemia-reperfusion in rats were evaluated by detecting the expression of tight junction proteins (ZO-1, Occludin, Claudin5) and mesenchymal marker proteins (α-SMA, Collagen I) in rat brain tissues by using western blotting, so as to further explore the possible mechanism of Col003 affecting BBB injury after cerebral ischemia-reperfusion in rats.
At 24 h and 72 h after cerebral ischemia-reperfusion, the expression level of HSP47 in the brain tissue of rats was significantly higher than that in the sham group (P < 0.0001). Compared with the model group, the neurological function scores (P < 0.05) and motor function scores (P < 0.01) of MCAO rats in butylphthalide group and Col003 group were significantly improved, the cerebral infarction area was significantly reduced (P < 0.0001), and the Evans blue permeability was significantly decreased (P < 0.0001). Compared with the model group, the expression of tight junction protein in the brain tissue of Col003 group was significantly increased (P < 0.01), and the expression of mesenchymal marker protein was significantly decreased (all P < 0.01).
Col003 can improve BBB injury after cerebral ischemia-reperfusion, and has a protective effect on BBB. Its protective effect on BBB may be achieved by inhibiting EndMT.
| [1] |
ZERNA C, THOMALLA G, CAMPBELL B C V, et al. Current practice and future directions in the diagnosis and acute treatment of ischaemic stroke[J]. Lancet, 2018, 392(10154): 1247-1256. doi: 10.1016/S0140-6736(18)31874-9
|
| [2] |
PAUL S, CANDELARIO-JALIL E. Emerging neuroprotective strategies for the treatment of ischemic stroke: An overview of clinical and preclinical studies[J]. Experimental neurology, 2021, 335: 113518. doi: 10.1016/j.expneurol.2020.113518
|
| [3] |
PIERA-VELAZQUEZ S, JIMENEZ S A. Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases[J]. Physiological reviews, 2019, 99(2): 1281-1324. doi: 10.1152/physrev.00021.2018
|
| [4] |
BAI Y, ZHANG Y, HAN B, et al. Circular RNA DLGAP4 ameliorates ischemic stroke outcomes by targeting miR- 143 to regulate endothelial-mesenchymal transition associated with blood-brain barrier integrity[J]. Journal of neuroscience, 2018, 38(1): 32-50. doi: 10.1523/JNEUROSCI.1348-17.2017
|
| [5] |
LUO Y S, YANG H, WAN Y K, et al. Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-tomesenchy- mal transition[J]. Cell death disease, 2022, 13(5): 462. doi: 10.1038/s41419-022-04888-5
|
| [6] |
SAUK J J, NIKITAKIS N, SIAVASH H. Hsp47 a novel collagen binding serpin chaperone, autoantigen and therapeutic target[J]. Frontiers in bioscience, 2005, 10: 107-118. doi: 10.2741/1513
|
| [7] |
XIE S Y, XING Y, SHI W K, et al. Cardiac fibroblast heat shock protein 47 aggravates cardiac fibrosis post myocardial ischemia-reperfusion injury by encouraging ubiquitin specific peptidase 10 dependent Smad4 deubiquitination [J]. Acta pharmaceutica sinica B, 2022, 12(11): 4138-4153. doi: 10.1016/j.apsb.2022.07.022
|
| [8] |
XU-DUBOIS Y C, PELTIER J, BROCHERIOU I, et al. Markers of endothelial-to-mesenchymal transition: evidence for antibody-endothelium interaction during antibody-mediated rejection in kidney recipients[J]. Journal of American society of nephrology, 2016, 27(1): 324-332. doi: 10.1681/ASN.2014070679
|
| [9] |
HIGASHI T, TAKECHI H, UEMURA Y, et al. Differential induction of mRNA species encoding several classes of stress proteins following focal cerebral ischemia in rats [J]. Brain research, 1994, 650(2): 239-248. doi: 10.1016/0006-8993(94)91787-6
|
| [10] |
ITO S, OGAWA K, TAKEUCHI K, et al. A small-molecule compound inhibits a collagen-specific molecular chaperone and could represent a potential remedy for fibrosis[J]. Journal of biological chemistry, 2017, 292(49): 20076-20085. doi: 10.1074/jbc.M117.815936
|
| [11] |
WU S, LIANG C W, XIE X Y, et al. Hsp47 inhibitor Col003 attenuates collagen-induced platelet activation and cerebral ischemic-reperfusion injury in rats[J]. Frontiers in pharmacology, 2022, 12: 792263. doi: 10.3389/fphar.2021.792263
|
| [12] |
ZHANG D Y, JIN W D, LIU H L, et al. ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats[J]. Experimental neurology, 2020, 331: 113362. doi: 10.1016/j.expneurol.2020.113362
|
| [13] |
BEDESON J B, PITTS L H, TSUJI M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination[J]. Stroke, 1986, 17(3): 472-476. doi: 10.1161/01.STR.17.3.472
|
| [14] |
MORAN P M, HIGGINS L S, CORDELL B, et al. Agerelated learning deficits in transgenic mice expressing the 751-amino acid isoform of human β -amyloid precursor protein[J]. Proceedings of the national academy of sciences of the United States of America, 1995, 92(12): 5341- 5345.
|
| [15] |
SIFAT A E, VAIDYA B, ABBRUSCATO T J. Blood-brain barrier protection as a therapeutic strategy for acute ischemic stroke[J]. Aaps journal, 2017, 19(4): 957-972. doi: 10.1208/s12248-017-0091-7
|
| [16] |
KANG M, YAO Y. Basement membrane changes in ischemic stroke[J]. Stroke, 2020, 51(4): 1344-1352. doi: 10.1161/STROKEAHA.120.028928
|
| [17] |
SANDOVAL K E, WITT K A. Blood-brain barrier tight junction permeability and ischemic stroke[J]. Neurobiology of disease, 2008, 32(2): 200-219. doi: 10.1016/j.nbd.2008.08.005
|
| [18] |
OBERMEIER B, DANEMAN R, RANSOHOFF R M. Development, maintenance and disruption of the bloodbrain barrier[J]. Nature medicine, 2013, 19(12): 1584-1596. doi: 10.1038/nm.3407
|
| [19] |
CHEN D Q, LI L, WANG Y, et al. Ischemia-reperfusion injury of brain induces endothelial-mesenchymal transition and vascular fibrosis via activating let-7i/TGF- βR1 double-negative feedback loop[J]. Federation of American societies for experimental biology, 2020, 34(5): 7178-7191. doi: 10.1096/fj.202000201R
|
| [20] |
SUN D L, MA J, DU L Y, et al. Fluid shear stress induced-endothelial phenotypic transition contributes to cerebral ischemia-reperfusion injury and repair[J]. APL bioengeering, 2024, 8(1): 016110. doi: 10.1063/5.0174825
|
| [21] |
BELLAYE P S, BURGY O, BONNIAUD P, et al. HSP47: a potential target for fibrotic diseases and implications for therapy[J]. Expert opinion on therapeutic targets, 2021, 25(1): 49-62. doi: 10.1080/14728222.2021.1861249
|
| [22] |
KATO T, SEKIGUCHI A, SAGARA K, et al. Endothelialmesenchymal transition in human atrial fibrillation[J]. Journal of cardiology, 2017, 69(5): 706-711. doi: 10.1016/j.jjcc.2016.10.014
|
| [23] |
LOUIS K, HERTIG A, TAUPIN J L, et al. Markers of graft microvascular endothelial injury may identify harmful donor-specific anti-HLA antibodies and predict kidney allograft loss[J]. American journal of transplantation, 2019, 19(9): 2434-2445. doi: 10.1111/ajt.15340
|
| [24] |
HEMANTHAKUMAR K A, FANG S T, ANISIMOV A, et al. Cardiovascular disease risk factors induce mesenchymal features and senescence in mouse cardiac endothelial cells[J]. Elife, 2021, 10: e62678. doi: 10.7554/eLife.62678
|
| [25] |
STENMAN J M, RAJAGOPAL J, CARROLL T J, et al. Canonical wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature[J]. Science, 2008, 322(5905): 1247-1250. doi: 10.1126/science.1164594
|
| [26] |
LIU J Q, XIAO Q, XIAO J N, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities[J]. Signal transduction and targeted therapy, 2022, 7(1): 3. doi: 10.1038/s41392-021-00762-6
|
| [27] |
FEI Y X, ZHU J P, ZHAO B, et al. XQ-1H regulates Wnt/ GSK3β/β-catenin pathway and ameliorates the integrity of blood brain barrier in mice with acute ischemic stroke[J]. Brain research bulletin, 2020, 164: 269-288. doi: 10.1016/j.brainresbull.2020.08.032
|
| [28] |
FEI Y X, LI T, WU R Y, et al. Se-(Methyl)-selenocysteine ameliorates blood-brain barrier disruption of focal cerebral ischemia mice via ferroptosis inhibition and tight junction upregulation in an Akt/GSK3β-dependent manner [J]. Psychopharmacology (Berl), 2024, 241(2): 379-399. doi: 10.1007/s00213-023-06495-4
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
DownLoad: